3,0
12. Jan. 2009
Ehemaliger Mitarbeiter
Whitehouse Station, NJ
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
Great Benefits. It used to be the #1 pharmaceutical, at least in most therapeutic areas where it had a product competing, and it might be #1 again, but not soon.
Kontras
It is undergoing a major transformation, and most middle management (Sr. Directors, Directors, Managers) are trying to survive, even resisting change. New layoffs were announced for 2009, morale is low. Don't go to Comet, unless you enjoy pain.